Definitive Contract 75D30121C10170
Award Date
1/1/21
Potential Completion Date
12/31/30
Potential Value
$5.9M
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Haiti
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
22
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $13,523,501.30 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Research Institute Of The Mcgill University Health Centre for Tuberculosis Trials Consortium Services. The contract has a period of performance through December 31, 2030 and was awarded on January 1, 2021. It is a cost-no-fee contract to support clinical trials and research on the treatment, diagnosis, and prevention of tuberculosis, including studies of latent TB infection in...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Case Western Reserve University's Office of Research Administration Division, doing business as University Hospitals of Cleveland, with a ceiling value of $15,729,937.34. The contract is for tuberculosis trials and consortium services over a 10-year period of performance from January 1, 2021 to December 31, 2030. There is no set-aside designation for this award. The contract requires the vendor to...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Definitive Contract to The Trustees of Columbia University in the City of New York Sponsored Projects Administration Division (Columbia University) for the TUBERCULOSIS TRIALS CONSORTIUM (TBTC) project. The contract has a potential value of $523,857.39 and is a Cost No Fee type contract. The contract does not have a set-aside designation and was awarded on September 18, 2019 with a completion date of...
This is a $2,054,175.16 federal contract awarded by the Centers for Disease Control and Prevention (CDC) to PPD Development LP, a global contract research organization (CRO), for monitoring services in support of the Tuberculosis Trials Consortium (TBTC). The contract is a 5-year definitive contract with a time and materials pricing type. It will involve on-site monitoring, quality assurance, investigational product management, and reporting for TBTC clinical trials of new drugs, diagnostics,...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $1,434,867.00 definitive cost-no-fee contract to The Johns Hopkins University to support the Tuberculosis Trials Consortium (TBTC). This contract, which does not have a set-aside designation, was awarded on September 18, 2019 and has a completion date of March 17, 2021. The Johns Hopkins University, a private non-profit research university, will provide clinical trial and data coordination services...
The Centers for Disease Control and Prevention (CDC) awarded a $9,856,205.74 definitive contract to The Medical University of South Carolina (MUSC) for tuberculosis clinical trials and research support. The contract runs from January 1, 2021 to December 31, 2030 and does not have a set-aside designation. The University of Cape Town in South Africa is a major subcontractor, providing pharmacokinetics research support for the trials. This contract is part of the CDC's Tuberculosis Trials...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to King County, doing business as Public Health-Seattle & King County, for tuberculosis trials and consortium services. The $10,667,136.30 contract has an ultimate completion date of December 31, 2030. It does not have a set-aside designation, indicating it was competed on a full and open basis. The contract will support clinical trials and research on the treatment, diagnosis, and prevention of...
The Centers for Disease Control and Prevention (CDC) awarded a $4,455,976 cost-no-fee definitive contract to The Regents of the University of California, San Francisco (UCSF) to develop, implement, and evaluate interventions to improve latent tuberculosis infection (LTBI) identification and treatment among high-risk non-U.S.-born populations in primary care settings. This contract, known as Tuberculosis Epidemiologic Studies Consortium III (TBESC3), has a period of performance from September 29,...
The Centers for Disease Control and Prevention awarded a $154,876 delivery order contract to The Trustees of Columbia University in New York, New York. The contract supports research entitled "TB in the U.S.: Epidemiology and Prevention Opportunities" through September 14, 2010. As a private, non-profit educational institution, Columbia University will provide subject matter expertise and analysis to the CDC regarding tuberculosis trends, transmission dynamics, and strategies for...
Columbia University has been awarded a $3,145,990 delivery order against its $999,990 Other Transaction Agreement with the Centers for Disease Control and Prevention (CDC). The delivery order is for the TBES Consortium to provide research and development services in support of CDC's disease prevention and health promotion objectives. As part of its Other Transaction Agreement vehicle, Columbia University conducts scientific studies for CDC on topics such as infectious diseases, chronic...